C
Rydex Biotechnology Fund Class C RYCFX
NASDAQ
Recommendation
NAV
Total Assets
Dividend Yield
Turnover Ratio
Expense Ratio
Weiss Ratings RYCFX-NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Rating C
Reward Index Fair
Reward Grade C
Risk Index Fair
Risk Grade C-
Company Info RYCFX-NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Provider Rydex Funds
Manager/Tenure (Years) Michael P. Byrum (27), Adrian Bachman (2), Brendan Cain (2), 2 others
Website http://www.guggenheiminvestments.com
Fund Information RYCFX-NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Fund Name Rydex Biotechnology Fund Class C
Category Health
Sub-Category Healthcare Sector Equity
Prospectus Objective Specialty - Technology
Inception Date Mar 30, 2001
Open/Closed To New Investors Open
Minimum Initial Investment 2,500.00
Minimum Subsequent Investment --
Front End Fee --
Back End Fee 0.01
Dividends and Shares RYCFX-NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Dividend Yield 0.00%
Dividend RYCFX-NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Dividend Yield (Forward) 0.80%
Asset Allocation RYCFX-NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Cash 3.54%
Stock 99.82%
U.S. Stock 94.85%
Non-U.S. Stock 4.97%
Bond 0.00%
U.S. Bond 0.00%
Non-U.S. Bond 0.00%
Preferred 0.00%
Convertible 0.00%
Other Net -3.37%
Price History RYCFX-NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
7-Day Total Return -1.51%
30-Day Total Return 1.91%
60-Day Total Return 6.04%
90-Day Total Return 3.51%
Year to Date Total Return 2.38%
1-Year Total Return -5.70%
2-Year Total Return 9.92%
3-Year Total Return 8.76%
5-Year Total Return 1.46%
Price RYCFX-NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Closing Price --
1-Month Low Price --
1-Month High Price --
52-Week Low Price --
52-Week Low Price (Date) --
52-Week High Price --
52-Week High Price (Date) --
NAV RYCFX-NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Nav $41.58
1-Month Low NAV $40.25
1-Month High NAV $42.39
52-Week Low NAV $34.91
52-Week Low NAV (Date) Apr 08, 2025
52-Week High NAV $55.97
52-Week High Price (Date) Aug 21, 2024
Beta / Standard Deviation RYCFX-NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Beta 0.74
Standard Deviation 16.32
Balance Sheet RYCFX-NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Total Assets 82.73M
Operating Ratios RYCFX-NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Expense Ratio 2.40%
Turnover Ratio 79.00%
Performance RYCFX-NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Last Bull Market Total Return 14.45%
Last Bear Market Total Return -10.45%